FALCONE, COLOMBA
 Distribuzione geografica
Continente #
NA - Nord America 6.797
EU - Europa 5.773
AS - Asia 3.761
SA - Sud America 179
AF - Africa 22
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.547
Nazione #
US - Stati Uniti d'America 6.718
CN - Cina 3.101
IE - Irlanda 1.472
UA - Ucraina 968
FI - Finlandia 732
RU - Federazione Russa 646
DE - Germania 632
SG - Singapore 487
IT - Italia 469
SE - Svezia 368
GB - Regno Unito 226
BR - Brasile 151
FR - Francia 105
CA - Canada 69
BE - Belgio 51
HK - Hong Kong 40
IN - India 25
CZ - Repubblica Ceca 23
NL - Olanda 21
JP - Giappone 15
AU - Australia 11
TR - Turchia 11
AR - Argentina 10
AT - Austria 9
MU - Mauritius 8
IL - Israele 7
IR - Iran 7
CL - Cile 6
ES - Italia 6
IQ - Iraq 6
AM - Armenia 5
AZ - Azerbaigian 5
BD - Bangladesh 5
HU - Ungheria 5
LV - Lettonia 5
PK - Pakistan 5
UZ - Uzbekistan 5
BO - Bolivia 4
BY - Bielorussia 4
EG - Egitto 4
KG - Kirghizistan 4
MA - Marocco 4
PL - Polonia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
DO - Repubblica Dominicana 3
EC - Ecuador 3
EE - Estonia 3
EU - Europa 3
JO - Giordania 3
KR - Corea 3
LK - Sri Lanka 3
MX - Messico 3
NO - Norvegia 3
RO - Romania 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DK - Danimarca 2
ID - Indonesia 2
IS - Islanda 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PE - Perù 2
TJ - Tagikistan 2
TN - Tunisia 2
VE - Venezuela 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 16.547
Città #
Chandler 1.527
Dublin 1.471
Jacksonville 1.198
Nanjing 866
Boardman 454
Nanchang 355
Ashburn 347
Beijing 313
Princeton 279
Hebei 270
Shenyang 263
Lawrence 257
Ann Arbor 256
Medford 239
Changsha 234
Singapore 225
Helsinki 212
Jiaxing 194
Wilmington 192
Tianjin 158
Hangzhou 145
Moscow 112
Shanghai 105
Milan 92
New York 92
Woodbridge 68
Los Angeles 66
Seattle 63
Piscataway 58
Toronto 58
Brussels 51
Verona 48
Pavia 43
Norwalk 41
Hong Kong 35
Kunming 32
Des Moines 28
Falkenstein 27
Dearborn 21
Fairfield 20
Munich 20
The Dalles 17
Jinan 16
Turku 16
Brno 14
Ningbo 14
Zhengzhou 14
Berlin 13
Dallas 13
Lanzhou 13
Tokyo 13
Palermo 12
Pune 12
Auburn Hills 11
Houston 11
London 11
Rome 11
Frankfurt am Main 10
Guangzhou 10
San Francisco 10
Washington 10
Changchun 9
São Paulo 9
Tappahannock 9
Taizhou 8
Vienna 8
Canberra 7
Meda 7
Olomouc 7
Borås 6
Fuzhou 6
Leawood 6
Rio de Janeiro 6
Amsterdam 5
Baku 5
Bareggio 5
Belo Horizonte 5
Bologna 5
Brescia 5
Chicago 5
Gunzenhausen 5
Napoli 5
Nuremberg 5
Ottawa 5
Tel Aviv 5
Bishkek 4
Brasília 4
Bratislava 4
Buenos Aires 4
Cairo 4
Falls Church 4
Minsk 4
Naples 4
Orange 4
Redwood City 4
Riyadh 4
Tashkent 4
Trieste 4
Yerevan 4
Amman 3
Totale 10.993
Nome #
Ruolo dell'infiammazione e della risposta immune nell'aterosclerosi: studio del polimorfismo Asp299Gly del gene TLR4 (Toll Like Receptor 4) in pazienti CAD. 146
Studio di genere: possibile ruolo del polimorfismo Val66Met del BDNF nella malattia coronarica e nella depressione. 142
Riscontro ecocardiografico di apposizioni trombotiche nei pazienti con fibrillazione atriale: predittività del punteggio CHADS2 in relazione alla strategia di prevenzione degli eventi tromboembolici 124
Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia 112
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease 108
Age of Onset of Myocardial Infarction: Is Promoter Polymorphism of the RAGE Gene Implicated? 107
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 105
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 105
Analisi molecolare e immunocitochimica dell'espressione del gene RAGE in pazienti CAD (Coronary Artery Disease). 104
Ruolo dei polimorfismi del gene TNF e dei suoi recettori (TNFR1 e TNFR2) nello sviluppo di aterosclerosi coronarica 103
Studio del polimorfismo 14 bp inserzione/delezione nel gene HLA-G e insorgenza della CAD (Coronary Artery Disease) 103
CAD (Coronary Artery Disease) diabetes and HLA class III RAGE (Receptor for Advanced Glycation End products) gene polymorphisms. 98
Infarto miocardico ed età di insorgenza: è implicato il polimorfismo -374T/A del gene RAGE nello studio di genere? 97
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 95
Associazione tra il polimorfismo RAGE (Receptor for Advanced Glycation Endproducts) - 374 T/A e la presenza di diabete in soggetti CAD. 94
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 94
Atrial fibrillation recurrence and expression levels of apelin-regulating miRNAs 94
-374 T/A, -429 C/T and G82S polymorphisms of the receptor for advanced glycation endproducts (RAGE) gene (HLA class III) and risk of coronary artery disease (CAD) in Caucasian Italian subjects. 93
Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. 93
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 93
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 92
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 91
Does Nifedipine increased coronary flow during exercise in patients with exertional angina? 91
RAGE : a central player in nondiabetic vascular disease 90
Correlation between mucosal levels of receptor for advanced glycation end products (RAGE) with inflammatory indexes in crohn's disease and ulcerative colitis 90
Dental pain threshold and excercise-induced silent ischemia in hypertensive and normotensive patients 90
Peripheral benzodiazepine receptor (pBZR) expression on leucocytes in patients with ischemic heart disease 89
Associazione tra la concentrazione plasmatica di eotaxina e coronaropatia in pazienti sottoposti ad angiografia coronarica 88
-374T/A and -429 T/C polymorphisms of the RAGE gene in Myocardial Infarction. 85
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 85
Thrombolisis versus PTCA in patients with recent myocardial infarction: exercise stress echocardiography study 85
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 85
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 85
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 84
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 84
Aterosclerosi e CAD (Coronary artery disease): analisi dei polimorfismi del recettore CR1 84
Association between platelet endothelial cellular adhesion molecole 1 ( PECAM-1/CD31) polymorphisms and atherosclerosis: results of a study performed in patients from north Italy 83
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 83
Analysis of CR1 and CR2 polymorphisms in Italian patients with angiographically documented coronary artery disease (CAD). 83
Ruolo prognostico del polimorfismo -374 T/A del gene RAGE (recettore per i prodotti finali di glicazione avanzata) nei pazienti con sospetta coronaropatia 83
Effects of physical training on cardiovascular control after heart transplantation 83
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 82
Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy 82
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 82
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 82
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 81
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 81
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 81
A W148R mutation in the human FOXD4 gene segregating with dilated cardiomyopathy, obsessive-compulsive disorder, and suicidality 81
Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms 80
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 80
Cateterismo transettale con sistema a radiofrequenza: un nuovo approccio alternativo alla convenzionale puntura del setto con ago d’acciaio 78
Improvement in exercise capacity, right heart hemodynamics and right ventricular function after pulmonary endarterectomy in patients with chronic thromoboembolic pulmonary hypertension. 78
CORRELAZIONE TRA I LIVELLI PLASMATICI DI NEUROTROFINE, SINTOMATOLOGIA DEPRESSIVA E ATEROSCLEROSI CORONARICA 78
Therapeutic approach in patients with stable angina 77
Association between two polymorphisms in the HLA-G gene and angiographic coronaryartery disease 77
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 77
Signal averaged elettrocardiography in patients with chronic ischemic heart disease. 77
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 76
Effect of PTCA on hyperventilation induced vasomotor response in stable angina 76
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 75
Non-respiratory components of heart rate variability in heart transplant recipients: evidence of autonomic reinnervation? 75
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 75
POLIMORFISMO DEL GENE RAGE E MANIFESTAZIONI CLINICHE DELLA CARDIOPATIA ISCHEMICA 75
A double comparison of Nicoradil and isosprbide dinitrate slow release in patients with stable angina pectoris 75
Factors moduleting respiratory sinus arrhytmia during physical exercise in heart transplanted patients 75
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 75
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk 75
Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. 74
Polimorfismi del gene RAGE (Receptor for Advanced Glycation Endproducts) e CAD (Coronary Artery Disease): studio dell'implicazione nell'eterogeneità di malattia 74
Biomarcatori infiammatori e neuro-ormonali nella fibrillazione atriale persistente; ruolo prognostico della concentrazione plasmatica di apelina 74
Ormonoterapia e cardiopatia ischemica nella donna in menopausa. 74
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 74
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 74
Gene RAGE e cardiopatia ischemica: ruolo del polimorfismo –374 T/A nell’estensione della coronaropatia 73
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism 72
Study of the espression of receptor for advanced glycation end products (RAGE), in inflammatory bowel disease 72
Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina 72
Peripheral benzodiazepine receptors expression on leucocytes in patients with ischemic heart disease 72
Significance of the walk-through angina phenomenon during exercise testing 72
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 71
Relationship between the -374 T/A Rage polymorphism and severity of coronary atherosclerosis 71
Il six minute walking test è un indice attendibile nella valutazione del recupero funzionale nei pazienti con cuore polmonare cronico tromboembolico sottoposti ad endoarteriectomia polmonare 71
Increased production of inflammatory cytokines in patients with silent myocardial ischemia 71
Studio dei polimorfismi nel gene del recettore dell’apelina in pazienti con e senza ipertensione arteriosa 71
Transcutaneous Oxygen Tension as a Potential Predictor of Cardiovascular Events in Type 2 Diabetes: Comparison with ankle-brachial index 71
Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia 71
The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Study 71
Role of TNF and its receptors (TNFR1, TNFR2) in Coronary Artery Disease (CAD). 70
Dental pain threshold and angina pectoris in patients with coronary artery disease 70
Association between the -374 T/A polymorphism of RAGE gene and coronary artery disease 70
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 69
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 69
Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients 69
Associazione tra il polimorfismo -374 T/A del gene RAGE (HLA classe III) e lo sviluppo di ristenosi dopo angioplastica coronarica. 69
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. 69
Extension of coronary artery lesions and RAGE (HLA class III) promoter polymorphism 68
CD14 polymorphisms and ACS (Acute Coronary Syndromes) 68
Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated? 68
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 68
Totale 8.301
Categoria #
all - tutte 65.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 0 0 0 0 185 11
2020/20211.797 207 167 58 189 14 246 23 249 62 272 244 66
2021/20221.198 22 8 50 22 8 40 18 59 62 37 185 687
2022/20234.306 479 321 49 353 482 415 2 279 1.746 44 85 51
2023/20241.314 177 237 49 107 95 326 13 113 11 32 99 55
2024/20252.219 77 295 152 98 58 156 111 230 911 78 53 0
Totale 16.622